“A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS”, Braz. J. Pharm. Sci., vol. 54, no. 2, p. e17163, Jul. 2018, doi: 10.1590/s2175-97902018000217163.